93 results on '"Lanctôt, Krista L."'
Search Results
2. Sex‐specific neuropsychological correlates of apathy and depression across neurodegenerative disorders
3. Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico‐pathological study
4. Association between clinical dementia rating and clinical outcomes in Alzheimer's disease
5. Reduction of agitation and caregiver distress using a combination intervention of tetrahydrocannabinol and melatonin in dementia due to Alzheimer disease
6. Changes in Brain Glutathione in patients with mild vascular cognitive impairment
7. Investigating the effects of aerobic exercise primed anodal transcranial direct current stimulation on γ‐aminobutyric acid concentrations in mild vascular cognitive impairment
8. Beta to Theta Power Ratio in Electroencephalogram Periodic Components to Discriminate Mild Cognitive Impairment and Alzheimer’s Dementia
9. Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian LTC Residents With Dementia Before and During COVID‐19
10. Brain glutathione may be associated with white matter hyperintensities in patients with cardiovascular disease
11. Fluid Biomarkers of Neurodegeneration in Mild Cognitive Impairment: A Meta‐Analysis
12. Reduction of neuropsychiatric symptoms and associated caregiver distress using a tetrahydrocannabinol and melatonin combination in dementia due to Alzheimer’s disease
13. Changing the trajectory of Alzheimer’s disease: What is a meaningful delay in disease progression?
14. Investigating the impact of hypertension with and without diabetes on progression to Alzheimer’s disease: A clinic‐pathological study
15. Effect of tetrahydrocannabinol and melatonin combination on suicide ideation and behavior in dementia due to Alzheimer’s disease
16. Risk of motor vehicle collisions and culpability among older drivers using cannabis: a meta‐analysis
17. Profiles of modifiable dementia risk factors in later midlife: a latent class analysis
18. Reduction of apathy and caregiver distress using a combination of tetrahydrocannabinol and melatonin in dementia due to Alzheimer’s disease
19. Associations between homocysteine, tau, and neurodegenerative markers in apolipoprotein ε4 non‐carriers with clinical Alzheimer’s disease
20. Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders
21. Effect of the combination of tetrahydrocannabinol and melatonin (IGC‐AD1) on blood pressure variability in patients with mild to moderate Alzheimer’s Disease
22. Blood‐based biomarkers for predicting treatment response in the Apathy in Dementia Methylphenidate Trial 2 randomized clinical trial
23. Circulating cell‐free mitochondrial DNA (ccf‐mtDNA) and memory in mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
24. Association between lipopolysaccharide, immune biomarkers and cerebral amyloid‐beta deposition in older adults with mild cognitive impairment & major depressive disorder
25. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes
26. Association of sulfonylureas with the risk of dementia: A population‐based cohort study
27. Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders
28. Variability of response to exercise‐primed tDCS in those with mild cognitive impairment and Alzheimer’s disease (the EXPRESS study): a preliminary analysis
29. Lipid oxidation as a marker of apathy and executive dysfunction in patients at risk of vascular cognitive impairment
30. Heterogeneity of response to methylphenidate in apathetic patients in the ADMET 2 Trial
31. Association of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors with time to dementia: a population‐based cohort study
32. Boswellic acids (K‐Vie ™ ) improves clinical cognitive scores and reduces systemic inflammation in patients with mild to moderate Alzheimer’s disease.
33. Evaluating the relationship between endostatin and cognition in mild cognitive impairment (MCI), coronary artery disease (CAD), and Alzheimer’s disease (AD)
34. Identification and Treatment of Agitation in Nursing Home Settings: Applying the IPA Algorithm
35. Peripheral blood leukotriene B4 and E4 as biomarkers in Alzheimer’s disease
36. Differences in Alzheimer’s disease and cerebrovascular disease neuropathology between latent class groups of cardiovascular risk factors
37. Association between depression, gender and Alzheimer's neuropathology in older adults without dementia
38. Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study
39. Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
40. Leukotriene receptor antagonist use is associated with slower cognitive decline in Alzheimer’s disease
41. Apathy in Dementia Methylphenidate Trial 2 (ADMET2): Results of a phase III, placebo‐controlled, double‐blind, 6‐month, multi‐center, randomized clinical trial
42. Lipid peroxidation mediates the relationship between cardiopulmonary fitness and depressive symptoms in people with coronary artery disease
43. The association between brain‐derived neurotrophic factor and improved cognition in mild cognitive impairment and Alzheimer's disease patients in an exercise‐primed transcranial‐direct current stimulation study
44. Associations between the use of histamine‐2 receptor antagonists vs. proton pump inhibitors and cognitive decline: A stratified longitudinal study in people with and without cognitive impairment
45. Theta phase‐gamma amplitude coupling during working memory and its relationships with demographic, clinical, genetic, neurochemical, and neurostructural measures in older adults at risk for dementia
46. Oxidative stress mediates the effect of apathy on executive function in those at risk of vascular cognitive impairment
47. Apathy across neurodegenerative disorders is associated with sex‐specific changes in sub‐cortical and cortical grey matter volumes
48. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: A meta‐analysis
49. Altered central and peripheral glutathione in Alzheimer disease and mild cognitive impairment: A meta‐analysis
50. Apathy as a treatment target in neurocognitive disorders: Clinical trial implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.